ReviewPharmaceuticals (Basel, Switzerland)2021

Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy.

Xiaonan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.